Quick Takeaways
- Baselake Partners, LP filed SCHEDULE 13G for Athira Pharma, Inc. Common Stock, $0.0001 par value per share (ATHA).
- Disclosed ownership: 5%.
- Date of event: 07 Nov 2025.
Baselake Partners, LP - 07 Nov 2025 SCHEDULE 13G Report for Athira Pharma, Inc. Common Stock, $0.0001 par value per share (ATHA)
- Filing Manager
- Baselake Partners, LP
- Reporting Manager
- Baselake Partners, LP
- Symbol
- ATHA
- Shares outstanding
- 3,949,620 shares
- Disclosed Ownership
- 197,481 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 16:06:41 UTC
- Date of event
- 07 Nov 2025
- Next filing
- 06 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Baselake Partners, LP disclosed 5% ownership in Athira Pharma, Inc. Common Stock, $0.0001 par value per share (ATHA) on 07 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baselake Partners, LP | 5% | 197,481 | 0 | 197,481 | /s/ David Paolella | David Paolella, Managing Member of Baselake Management, LLC, its investment manager | |
| Baselake Management, LLC | 5% | 197,481 | 0 | 197,481 | /s/ David Paolella | David Paolella, Managing Member | |
| David Paolella | 5% | 197,481 | 0 | 197,481 | /s/ David Paolella | Individually |